Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma

Journal of Surgical Research

Volumn 198, Issue 1, 2015, Pages 73-79

  Li, Chuan ^a   Wen, Tian Fu ^a   Yan, Lu Nan ^a   Li, Bo ^a   Wang, Wen Tao ^a   Yang, Jia Yin ^a   Xu, Ming Qing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Neutrophil to lymphocyte ratio; Platelet to lymphocyte ratio

Indexed keywords

ALPHA FETOPROTEIN; ENTECAVIR; LAMIVUDINE; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR VOLUME; VIRUS LOAD; AGED; CARCINOMA, HEPATOCELLULAR; LEUKOCYTE COUNT; LIVER NEOPLASMS; LYMPHOCYTE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATHOLOGY; SURVIVAL RATE; THROMBOCYTE; THROMBOCYTE COUNT; TUMOR RECURRENCE;

ADULT; AGED; BLOOD PLATELETS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LEUKOCYTE COUNT; LIVER NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PLATELET COUNT; SURVIVAL RATE;

EID: 84938748032     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.05.003     Document Type: Article

References (31)

1. G. Fattovich, F. Bortolotti, and F. Donato Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 2008 335
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
3. European Association For The Study Of The Liver, European Organisation For Research, Treatment Of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908
4. N. Harimoto, K. Shirabe, H. Nakagawara, and et al. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio Transplantation 96 2013 1008
5. T.M. Chen, C.C. Lin, P.T. Huang, and C.F. Wen Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation J Gastroenterol Hepatol 27 2012 553
6. W. Liao, J. Zhang, Q. Zhu, and et al. Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection Transl Oncol 7 2014 248
7. T. Terashima, T. Yamashita, N. Iida, and et al. Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy Hepatol Res 2014 10.1111/hepr.12436
8. X. Li, Z.H. Chen, Y.F. Xing, and et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma Tumour Biol 36 2015 2263
9. A. Kinoshita, H. Onoda, N. Imai, and et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma Br J Cancer 107 2012 988
10. I. Parisi, E. Tsochatzis, H. Wijewantha, and et al. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria Liver Transpl 20 2014 1327
11. K. Yamamura, H. Sugimoto, M. Kanda, and et al. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection J Hepatobiliary Pancreatic Sci 21 2014 682
12. S.S. Zheng, X. Xu, J. Wu, and et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726
13. G. Fattovich, G. Giustina, S.W. Schalm, and et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis Hepatology 21 1995 77
14. J. Zhang, Y. Zhao, Y. Bai, G. Lv, J. Wu, and Y. Chen The significance of serum uric acid level in humans with acute paraquat poisoning Sci Rep 5 2015 9168
15. Y. Mano, K. Shirabe, Y. Yamashita, and et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis Ann Surg 258 2013 301
16. K.J. Halazun, M.A. Hardy, A.A. Rana, and et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg 250 2009 141
17. T. Motomura, K. Shirabe, Y. Mano, and et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment J Hepatol 58 2013 58
18. P. Guo, S.L. Shen, Q. Zhang, and et al. Prognostic evaluation of categorical platelet-based indices using clustering methods based on the Monte Carlo comparison for hepatocellular carcinoma Asian Pac J Cancer Prev 15 2014 5721
19. E. Sierko, and M.Z. Wojtukiewicz Platelets and angiogenesis in malignancy Semin Thromb Hemost 30 2004 95
20. B.I. Carr, A. Cavallini, R. D'Alessandro, and et al. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro BMC Cancer 14 2014 43
21. G. Sitia, R. Aiolfi, P. Di Lucia, and et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B Proc Natl Acad Sci U S A 109 2012 E2165
22. C.Y. Wu, Y.J. Chen, H.J. Ho, and et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection JAMA 308 2012 1906
23. J. Dan, Y. Zhang, Z. Peng, and et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation PloS one 8 2013 e58184
24. Q. Lai, E. Castro Santa, J.M. Rico Juri, R.S. Pinheiro, and J. Lerut Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer Transpl Int 27 2014 32
25. N. Harada, K. Shirabe, T. Maeda, H. Kayashima, T. Ishida, and Y. Maehara Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients World J Surg 39 2015 1044
26. Y. Cui, and J. Jia Update on epidemiology of hepatitis B and C in China J Gastroenterol Hepatol 28 Suppl 1 2013 7
27. M.D. Kluger, J.A. Salceda, A. Laurent, and et al. Liver resection for hepatocellular carcinoma in 313 western patients: tumor biology and underlying liver rather than tumor size drive prognosis J Hepatol 62 2015 1131
28. G. Lin, J. Wang, X. Lao, and et al. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells J Immunother 35 2012 337
29. L.N. Hammad, S.M. Abdelraouf, F.S. Hassanein, W.A. Mohamed, and M.F. Schaalan Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicology 10 2013 380
30. S.L. Shen, S.J. Fu, B. Chen, and et al. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection Ann Surg Oncol 21 2014 3802
31. A. Kinoshita, H. Onoda, N. Imai, and et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma Ann Surg Oncol 22 2015 803